Skip to main content
Log in

Hypertension increases risk of romosozumab cardiac and cerebrovascular events

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Kotake K, et al. Evaluation of Risk of Cardiac or Cerebrovascular Events in Romosozumab Users Focusing on Comorbidities: Analysis of the Japanese Adverse Drug Event Report Database. . Journal of Pharmacy Technology 39: 23-28, No. 1, Feb 2023. Available from: URL: http://doi.org/10.1177/87551225221144960

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hypertension increases risk of romosozumab cardiac and cerebrovascular events. Reactions Weekly 1945, 8 (2023). https://doi.org/10.1007/s40278-023-34089-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-34089-6

Navigation